MINNEAPOLIS - January 22, 2014 - Medtronic, Inc. (MDT), today announced that the Medtronic SureScan ® pacing systems - the first and only pacing systems in the United States that have been approved by ...

Medtronic, Inc. ( MDT) recently announced that it got the U.S. Food and Drug Administration's (FDA) approval to use its SureScan pacing systems for full body magnetic resonance imaging (MRI) scans ...

DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration ...

New Option in Second-Generation Pacing System Available in Select European Geographies Features Exclusive Technology and Allows Access to Critical Diagnostic Tool MINNEAPOLIS--(BUSINESS WIRE)-- ...

DUBLIN - July 12, 2018 - Medtronic plc (MDT) today announced U.S. Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure(TM) MRI SureScan(TM) Model 3830 cardiac pacing ...

Single-Chamber Pacemaker Allows for Full-Body MRI Scans Without Positioning Restrictions DUBLIN, Medtronic plc, today announced the U.S. Food and Drug Administration (FDA) approval and commercial ...

The FDA approves Medtronic's (MDT-1.1%) Evera SureScan implantable cardioverter defibrillator (ICD) System for MRI scans on any part of the body without positioning restrictions. It is the first such ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has ...

Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin ...

The news, however, failed to shoot the share price up. In fact, the shares went down marginally, ending the session at $59.15 as on Jan 22. The muted market reaction on this positive news could be due ...